
|Articles|October 29, 2020
Episode 68: Rocking Garage Biotech
Author(s)Elaine Quilici
Panna Sharma, CEO of Lantern Pharma, discusses garage biotech, what he’s learned from the culture, and how it might help transform certain areas of pharma, including innovation and pricing.
Advertisement
Panna Sharma, CEO of Lantern Pharma, discusses garage biotech, what he’s learned from the culture, and how it might help transform certain areas of pharma, including innovation and pricing.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharma M&A Roundup: Servier Acquiring Edgewise Therapeutics' Muscular Dystrophy Business, Hanmi Enters Licensing Agreement with Eli Lilly, Avenzo Enters Merger Agreement with Rallybio
2
FDA Approves Xocova as First Oral Post-Exposure Covid-19 Prevention Therapy
3
CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo
4
Why Breakthrough Cell and Gene Therapies Still Fail at the Finish Line
5
